quaterin
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT01831011)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
C[N+](C)(C)NCCC(=O)[O-]- Mol. weight
- 146.19 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2104708 ↗
Also known as
- 3-(2,2,2-trimethylhydrazine)propionate
- 3-(2,2,2-trimethylhydrazinium)propionate
- 3-tmhp
- meldonium
- meldonium
- meldonium
- met-88
- mildronat
- mildronate
- mildronate
- mildronate
- mildronate
- mildronate
- mildronate
- mindronate
- n-trimethylhydrazine-3-propionate
- q-4224-ios
- quaterin
- quaterin
- trimethylhydraziniumpropionate
- vasonat
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01800357 | Phase 2 | Jan 1, 2013 | People's Liberation Army of China |
| NCT01831011 | Phase 2 | Jul 1, 2008 | People's Liberation Army of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| People's Liberation Army of China | Government | 2 | 2 | 1 | 2008 |
1 organizations
Page 1 / 1